HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.

AuthorsPasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Massimiliano Palombi, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Luca Cupelli, Stefano Fratoni, Nélida Inés Noguera, Gianfranco Catalano, Paolo de Fabritiis
JournalActa oncologica (Stockholm, Sweden) (Acta Oncol) Vol. 56 Issue 10 Pg. 1331-1333 (10 2017) ISSN: 1651-226X [Electronic] England
PMID28488914 (Publication Type: Case Reports, Letter)
Chemical References
  • Antimetabolites, Antineoplastic
  • Decitabine
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Adult
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Decitabine (therapeutic use)
  • Female
  • Humans
  • Janus Kinase 2 (genetics)
  • Leukemia, Myeloid, Acute (drug therapy, genetics, pathology)
  • Neoplasms, Multiple Primary (drug therapy, genetics, pathology)
  • Thrombocythemia, Essential (genetics, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: